ADA 2023 Preview - New Method of A1c Testing for Better Diabetes Management and Diagnosis
Orange Biomed will be hosting a presentation at the upcoming 83rd ADA 2023 Scientific Sessions in San Diego, California from June 23 - 26th.
ADA 2023 Preview - New Method of A1c Testing for Better Diabetes Management and Diagnosis
Health Inequity in Communities of Color: Why Education and Early Testing Are Life-Saving
The AADA Is Leading the Fight Against Diabetes and Health Inequity
90% of Medical Device Waste Consists of Single-Use Devices - How to improve sustainability
Adding Routine A1c Testing to ER Visits Can Save Lives; How a Patient Reversed Diabetes Diagnosis
5 Women Making Strides in Diabetes Care and Advocacy in 2023
Orange Biomed Talks Expanding U.S. Collaborations with Leaders like Mayo Clinic Laboratories
Black Patients Typically Have Higher Hemoglobin Variants, Resulting In Inaccurate A1c Measurements
Portable A1c Devices Help Patients Better Control Type 2 Diabetes Post-Diagnosis
Diabetes Management Technology Poses Issues with Older U.S. Populations
2023 Gaps in Diabetes Care: How Providers Can Increase Awareness of Prediabetes Amongst Patients
NY’s New Diabetes Initiatives Serve as an Example for Other States to Prioritize A1c Management
Is There a Way To Reverse Type 2 Diabetes? Here's What You Need To Know
Immediate PoC A1c Test Results Increase Critical Diabetes Intervention By Over 50%
$1 Out of Every $4 in U.S. Healthcare Costs is Spent on Diabetes Treatment